Respiratory drugs and devices Market Market Trends, Size, Competitive Analysis and Forecast - 2018-2023


Posted October 15, 2020 by pooja1919

Respiratory drugs devices market size was estimated to USD 62,035 million in 2018 and expected to grow at a CAGR of 7% for the forecasted period of 2018-2023.
 
Respiratory drugs devices market size was estimated to USD 62,035 million in 2018 and expected to grow at a CAGR of 7% for the forecasted period of 2018-2023. The market is driven by the growing prevalence of respiratory diseases and disorders. There is been constant growth in the number of cases of asthma and COPD. Asthma and COPD account for approximately 60% of the respiratory drugs and devices market. An aging population and major lifestyle changes have led to a rise in respiratory diseases. Habits such as overeating, smoking, lack of exercise and other major lifestyle changes are causing respiratory diseases. Cases of the respiratory disorder are also on a rise in new-born.
Request a free sample of our report on Respiratory drugs and devices Market Market: https://www.omrglobal.com/request-sample/respiratory-drugs-devices-market

Respiratory drugs and devices companies are concentrating on developing new products. Companies are expanding their product portfolios and increasing their R&D budget. Major respiratory devices include therapeutic devices such as masks, ventilators, humidifiers, positive airway pressure devices and other devices. Other respiratory devices include diagnostic and monitoring devices and consumables and accessories meters. Respiratory drugs segmented on the basis of route of administration and drugs class.
A full report of Respiratory drugs and devices Market Market Is available at https://www.omrglobal.com/industry-reports/respiratory-drugs-devices-market

Respiratory drugs and devices Market segmentation
By product
Respiratory therapeutic devices
Respiratory positive airway pressure devices
Respiratory continuous positive airway pressure (cpap) devices
Respiratory automatic pap (apap) devices
Respiratory bi-level pap (bpap) devices
Respiratory masks
Respiratory nasal masks
Respiratory full-face masks
Respiratory nasal pillow masks
Respiratory oral masks
Respiratory ventilators
Respiratory adult ventilators
Respiratory infant/neonatal ventilators
Respiratory nebulizers
Respiratory humidifiers
Respiratory heated humidifiers
Respiratory passover humidifiers
Respiratory oxygen concentrators
Respiratory fixed oxygen concentrators
Respiratory portable oxygen concentrators
Respiratory inhalers
Respiratory dry powder inhalers (dpis)
Respiratory metered dose inhalers
Respiratory reusable resuscitators
Respiratory adult resuscitators
Respiratory infant/neonatal resuscitators
Respiratory nitric oxide delivery units
Respiratory oxygen hoods
Respiratory diagnostic and monitoring devices
Respiratory pulse oximeters
Respiratory pulse oximeter sensors
Respiratory pulse oximeter equipment
Respiratory capnographs
Respiratory gas analyzers
Respiratory spirometers
Respiratory polysomnography (psg) devices
Respiratory peak flow meters
Respiratory consumables and accessories meters
Respiratory disposable masks meters
Respiratory disposable resuscitators meters
Respiratory tracheostomy tubes meters
Respiratory nasal cannulas meters
Respiratory other consumables and accessories meters
By respiratory drugs
Respiratory drugs by route of administration
Oral respiratory drugs
Injectable respiratory drugs
Inhalable respiratory drugs
By drug class
Anticholinergics
Antihistamines
Beta2 agonists
Antiasthmatic combinations
Corticosteroids
Leukotriene inhibitors
Mast cell stabilizers
Phosphodiesterase 4 (pde4) inhibitors
Bronchodilators
Decongestants
Expectorants
Other respiratory drugs
By end users
Hospitals
Home care
Other end users
Competitive landscape
Key strategy analysis
Key company analysis
Regional analysis
North america
United states
Canada
Rest of north america
Europe
United kingdom
France
Germany
Italy
Spain
Rest of europe
Asia pacific
India
China
Japan
Rest of the world
Company profiles
Astrazeneca
Adamis (admp)
Ads biotechnology
Air liquide
Alios biopharma inc.
Alung technologies
Alvogen
Anaxsys
Applied biocode inc
Aptimmune biologics inc
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/respiratory-drugs-devices-market
About Us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Mr. Anurag Tiwari
Country India
Categories Business
Last Updated October 15, 2020